Cerebral metabolic changes in alzheimer’s disease: Neurobehavioral patterns

Dementia and Geriatric Cognitive Disorders

Volumn 7, Issue 5, 1996, Pages 239-245

  Blesa, Rafael ^a   Mohr, Erich ^b   Miletich, Robert S ^c   Hildebrand, Kathleen ^b   Sampson, Margaret ^b   Chase, Thomas N ^d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF OTTAWA   (Canada)

^c DENT NEUROLOGIC INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Alzheimer s disease; Behavioral neuroanatomy; Cerebral glucose metabolism; Positron emission tomography

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; ASSOCIATION CORTEX; BEHAVIOR; BRAIN METABOLISM; BRAIN SLICE; BRAIN STEM; BRAIN TOMOGRAPHY; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; LIMBIC SYSTEM; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSORIMOTOR CORTEX; THALAMUS;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BEHAVIOR; BRAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029758367     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106886     Document Type: Article

References (51)

1. Bennett DA, Evans DA: Epidemiology and public health impact of Alzheimer's disease. DisMon 1992:38:13-64.
2. Tomlinson BE, Blessed G, Roth M: Observations on the brains of demented old people. J Neurol Sei 1970:11:205-242.
3. Alavi A, Jolles PR, Jamieson DG, Rcivich M, Chawluk J: Anatomic and functional changes of the brain in normal aging and dementia as demonstrated by MR1. CT, and PET. Nucl MedAnnu 1989:49-79.
4. Ball MJ: Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. Acta Ncuropathol (Bcrl) 1977:37:111-118.
5. Cummings JL, Benson DF: Dementia: A Clinical Approach, ed 2. Boston, Buttcrworth-Hci-nemann, 1992.
6. Brun A: An overview of light and electron microscopic changes; in Reisberg B (ed): Alzheimer's Disease: The Standard Reference. New York. The Free Press. 1983. pp 37-47.
7. McKhann G, Drachman D, Folstein M, Katz-man R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA working group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984:34:939-944.
8. Phelps ME, Mazziotta JC, Huang SC: Study of cerebral function with positron computed tomography. J Cereb Blood Flow Mctab I982;2: 113-162.
9. Ferris SH, De Leon MJ, Wolf AP, Farkas T, Christman DR, Reisberg B, Fowler JS, MacGregor R, Goldman A, George AE: Positron emission tomography in the study of aging and senile dementia. Ncurobiol Aging 1980:1:127-131.
10. Guze BH, Hoffman JM, Baxter LRJ, Mazziotta JC, Phelps ME: Functional brain imaging and Alzheimer-type dementia. Alzheimer Dis Assoc Disord 1991;5:215-230.
11. Alavi A, Dann R, Chawluk J, Alavi J, Kushner M, Reivich M: Positron emission tomography imaging of regional cerebral glucose metabolism. Semin Nucl Med 1986;16:2-34.
12. Alavi A, Hirsch LJ: Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: Evolution over the past 2 decades. Semin Nucl Med 1991:21:58-81.
13. Brady CL, Rapoport SI: Cerebral metabolism in aging and dementia: in Birren JE, Sloanc RB (eds): Handbook of Mental Health and Aging. New York. Academic Press. 1992. pp 201 -223.
14. Phelps ME, Mazziotta JC: Positron emission tomography: Human brain function and biochemistry. Science 1985;228:799-809.
15. Wegener WA, Alavi A: Positron emission tomography in the investigation of ncuropsy-chiatric disorders: Update and comparison with magnetic resonance imaging and computerized tomography. Nucl Med Biol 1991:18: 569-582.
16. Hciss WD, Szclies B, Kessler J, Herholz K: Abnormalities of energy metabolism in Alzheimer's disease studies with PET. Ann N Y Acad Sei 1991;640:65-71.
17. Alavi A, Newberg AB, Souder E, Berlin JA: Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: Atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J Nucl Med 1993;34:1681-1687.
18. Foster NL, Chase TN, Mansi L, Brooks R, Fedio P, Patronas NJ, Di Chiro G: Cortical abnormalities in Alzheimer's disease. Ann Neurol 1984;16:649-654.
19. Herholz K, Adams R, Kessler J, Szelies B, Grond M, Heiss W-D: Criteria for the diagnosis of Alzheimer's disease with positron emission tomography. Dementia 1990;1:156-164.
20. Murphy DGM, Bottomlcy PA, Salerno JA, De-Carli C, Mentis MJ, Grady CL, Teichberg D, Giacometti KR, Rosenberg JM, Hardy CJ: An in vivo study of phosphorus and glucose metabolism in Alzheimer’s disease using magnetic resonance spectroscopy and PET. Arch Gen Psychiatry 1993;50:341-349.
21. Chawluk J, Alavi A, Hurtig H, Dann R, Rosen M, Kushner MJ, Silver FL, Reivich M: Altered patterns of regional cerebral glucose metabolism in aging and dementia. J Cereb Blood Flow Metab 1985;5:S 121-S122.
22. De Leon M, Ferris S, George A, Christman DR, Fowler JS, Gentes C, Reisberg B, Gee B, Emmerich M, Yonekura Y, Brodie J, Kricheff H, Wolf AP: Positron emission tomographic studies of aging and Alzheimer’s disease. Am J Ncuroradiol 1983:4:568-571.
23. Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, Moore A, Schlageter N, Larson S, Rapoport SI: Positron emission tomography in Alzheimer’s disease. Neurology 1986;36:879-887.
24. Goto I, Taniwaki T, Hosokawa S, Olsuka M, Ichiya Y, Ichimiya A: Positron emission tomographic (PET) studies in dementia. J Neurol Sci 1993;114:1-6.
25. Smith GS, De Leon MJ, George AE, Kluger A, Volkow ND, McRae T, Golomb J, Ferris SH, Reisberg B, Ciaravino J: Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer’s disease. Pathophysiologic implications. Arch Neurol 1992:49:1142-1150.
26. Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, Fricdland RP, Rapoport SI: High-resolution PET studies in Alzheimer’s disease. Ncuropsychopharmacology 1991;4:35-46.
27. McGeer EG, Peppard RP, McGeer PL, Tuok-ko H, Crockett D, Parks R, Akiyama H, Caine DB, Beattie BL, Harrop R: 18Fluorodeo.\yglu-cose positron emission tomography studies in presumed Alzheimer eases, including 13 serial scans. Can J Neurol Sci 1990;17:1-11.
28. Rapoport SI, Horwitz B, Grady CL, Haxby J V, DeCarli C, Schapiro MB: Abnormal brain glucose metabolism in Alzheimer's disease, as measured by positron emission tomography. Adv Exp Med Biol 1991;291:231-248.
29. Weinstein HC, Scheltcns P, Hijdra A, Van Royen EA: Neuro-imaging in the diagnosis of Alzheimer’s disease. II. Positron and single photon emission tomography. Clin Neurol Ncurosurg 1993;95:81-91.
30. Mesulam M-M: Patterns in behavioral neuro-anatomy: Association areas, the limbic system, and hemispheric specialization; in Mesulam M-M (ed): Principles of Behavioral Neurology. Philadelphia, Davis, 1985, pp 1-70.
31. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, rev, ed 3. Washington. American Psychiatric Association. 1987.
32. Sank VJ, Brooks RA, Friauf WS, Leighton SB, Cascio HE, Di Chiro G: Performance evaluation and calibration oi the Neuro-Pet scanner. IEEE Trans Nucl Sci 1983;NS-30:636-639.
33. Brooks RA, Friquf WS, Sank VJ, Cascio HE, Leighton SB, Di Chiro G: Initial evaluation of a high resolution positron emission tomograph; in Grcitz T. lngvar DH, Widen L (eds): The Metabolism of the Human Brain Studied with Positron Emission Tomography. New York. Raven Press, 1985. pp 57-68.
34. Aquilonius SM, Eckemas SA: A Colour Atlas of the Human Brain. New York, Raven Press. 1980.
35. Friedland RP, Brun A, Budinger TF: Pathological and positron emission tomographic correlations in Alzheimer's disease. Lancet 1985:i: 228.
36. Pearson RCA, Esiri MM, Hioms RW, Wilcock GK, Powell TP: Anatomical correlates of the distribution of the pathological changes in the ncocortex in Alzheimer disease. Proc Natl Acad Sci USA 1985;82:4531-4534.
37. Hauw J-J, Duyckaerts C, Dclaerc P, Piette F: Topography of lesions in Alzheimer's disease: A challenge to morphologists; in Rapoport SR. Petit H, Leys D, Christen Y (eds): Imaging, Cerebral Topography and Alzheimer's Disease. Berlin. Springer, 1990, pp 53-67.
38. Davis PC, Mirra SS, Alazraki N: The brain in older persons with and without dementia: Findings on MR. PET, and SPECT images. Am J Roentgenol 1994;162:1267-1278.
39. Fazekas F, Alavi A, Chawluk JB, Zimmerman RA, Hackney D, Bilaniuk L, Rosen M, Alves WM, Hurtig HI, Jamieson DG: Comparison of CT. MR. and PET in Alzheimer's dementia and normal aging. J Nucl Med 1989:30:1607-1615.
40. McGcer PL, McGeer EG, Akivama H, Harrop R: Regional deficits in cortical metabolism in PET-scanncd Alzheimer cases correlate with postmortem indices of gliosis, and not with choline acctyltransferasc: in Iqbal K. Mclach-lan DRC. Winblad B. Wisniewski HM (eds); Alzheimer's Disease: Basis Mechanisms. Diagnosis and Therapeutic Strategies. Chichester. Wiley & Sons. 1991. pp 59-68.
41. Masliah E, Terry RD, DeTcresa R, Hansen LA: lmmunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer’s disease. Neurosci Lett 1989:103:234-238.
42. Davies CA, Mann DMA, Sumpter PQ, Yates PO: A quantitative morphomctric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 1987.78:151-164.
43. Bertoni-Freddari C, Fattoretti P, Casoli T, Meier-Ruge W, Ulrich J: Morphological adaptive response of synaptic junctional zones in the human dentate gyrus during aging and Alzheimer’s disease. Brain Res 1990.517:69-75.
44. Hover S: Intermediary metabolism disturbance in AD/SDAT and its relation to molecular events. Prog Ncuropsychopharmacol Biol Psychiatry 1993:17:199-228.
45. DeKosky ST, Sciteli SW: Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann Neurol 1990:27:457-464.
46. Morrison JH, Hof PR, Campbell MJ, De Lima AD, Voigt T, Bouras C, Cox K, Young WG: Cellular pathology in Alzheimer's disease: implications forcorticocortieal disconnection and differential vulnerability: in Rapoport SR. Petit H. Leys D. Christen Y (eds): Imaging. Cerebral Topography and Alzheimer's Disease. Berlin. Springer. 1990. pp 19-39.
47. Buell SJ, Coleman PD: Dendritic growth in the aged human brain and failure of growth in senile dementia. Science 1979:206:854-856.
48. Horwitz B, Grady CL, Schlageter NL, Duara R, Rapoport SI; Intcrcorrelations of regional cerebral glucose metabolic rales in Alzheimer's disease. Brain Res 1987:407:294.
49. Azari NP, Rapoport SI, Grady CL, Sehapiro MB, Salerno JA, Gonzalez-Aviles A, Horwitz B: Patterns of interregional correlations of cerebral glucose metabolic rates in patients with dementia of the Alzheimer type. Neurodegeneration 1992:1:45-54.
50. Azari NP, Pettigrew KD, Sehapiro MB, Ilaxby JV, Grady CL, Pietrini P, Salerno JA, Heston LL, Rapoport SI, Horwitz B: Early detection of Alzheimer's disease: A statistical approach using positron emission tomographic data. J Ce-reb Blood Flow Mctab 1993:13:438-447.
51. Blesa R, Mohr E, Mileiich RS, Chase TN: Limbic system dysfunction in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1995:59:450-451.